BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 10604483)

  • 1. Physiologic tailoring of therapy for resistant hypertension: 20 years' experience with stimulated renin profiling.
    Spence JD
    Am J Hypertens; 1999 Nov; 12(11 Pt 1):1077-83. PubMed ID: 10604483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cutoff value of aldosterone-to-renin ratio for the diagnosis of primary aldosteronism in patients taking antihypertensive medicine.
    Niizuma S; Nakahama H; Kamide K; Fukuchi K; Iwanaga Y; Nakata H; Yoshihara F; Horio T; Nakamura S; Kawano Y
    Clin Exp Hypertens; 2008 Oct; 30(7):640-7. PubMed ID: 18855267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of laparoscopic adrenalectomy for hyperaldosteronism.
    Pang TC; Bambach C; Monaghan JC; Sidhu SB; Bune A; Delbridge LW; Sywak MS
    ANZ J Surg; 2007 Sep; 77(9):768-73. PubMed ID: 17685956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normokalemic hyperaldosteronism in patients with resistant hypertension.
    Benchetrit S; Bernheim J; Podjarny E
    Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Long-term dispensary observation of patients with so-called low-renin forms of arterial hypertension].
    Patrusheva IF; Iurenev AP
    Ter Arkh; 1987; 59(7):101-3. PubMed ID: 3313782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary aldosteronism: renaissance of a syndrome.
    Young WF
    Clin Endocrinol (Oxf); 2007 May; 66(5):607-18. PubMed ID: 17492946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Screening tests and diagnostic examinations of hypertensives for primary aldosteronism].
    Omura M; Nishikawa T
    Rinsho Byori; 2006 Nov; 54(11):1157-63. PubMed ID: 17240838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Current aspects of diagnosis and treatment of symptomatic arterial hypertension of adrenal genesis].
    Shevchenko IuL; Vetshev PS; Podzolkov VI; Ippolitov LI; Rodionov AV; Polunin GV
    Ter Arkh; 2003; 75(4):8-15. PubMed ID: 12793129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathology of the adrenal gland in refractory low-renin hypertension.
    Longo DL; Esterly JA; Grim CE; Keitzer WF
    Arch Pathol Lab Med; 1978 Jun; 102(6):322-7. PubMed ID: 580727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of biochemical tests and clinical symptoms in differential diagnosis of primary aldosteronism.
    Prejbisz A; Postuła M; Cybulska I; Dobrucki T; Kabat M; Peczkowska M; Janas J; Janaszek-Sitkowska H; Makowiecka-Cieśla M; Januszkiewicz A
    Kardiol Pol; 2003 Jan; 58(1):17-26. PubMed ID: 14502298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.
    Khan NA; McAlister FA; Campbell NR; Feldman RD; Rabkin S; Mahon J; Lewanczuk R; Zarnke KB; Hemmelgarn B; Lebel M; Levine M; Herbert C;
    Can J Cardiol; 2004 Jan; 20(1):41-54. PubMed ID: 14968142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does aldosterone-to-renin ratio predict the antihypertensive effect of the aldosterone antagonist spironolactone?
    Mahmud A; Mahgoub M; Hall M; Feely J
    Am J Hypertens; 2005 Dec; 18(12 Pt 1):1631-5. PubMed ID: 16364838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The aldosterone to Renin ratio in secondary hypertension].
    Seiler L; Reincke M
    Herz; 2003 Dec; 28(8):686-91. PubMed ID: 14689102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prevalence of a raised aldosterone-renin ratio (ARR) among new referrals to a hypertension clinic.
    Williams D; Croal B; Furnace J; Ross S; Witte K; Webster M; Critchen W; Webster J
    Blood Press; 2006; 15(3):164-8. PubMed ID: 16864158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hypertension and primary hyperaldosteronism].
    Plouin PF; Fiquet-Kempf B; Fakhoudi F; Rezolle JP; Guéry B
    Arch Mal Coeur Vaiss; 2000 Nov; 93(11 Suppl):1469-73. PubMed ID: 11190297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypertension management: differing points of view. Should we routinely measure renin levels to diagnose and treat patients with hypertension? The argument against.
    Weinberger MH
    J Clin Hypertens (Greenwich); 2005 Jan; 7(1):36-7; quiz 38-9. PubMed ID: 15655386
    [No Abstract]   [Full Text] [Related]  

  • 17. Endocrine arterial hypertension: therapeutic approach in clinical practice.
    Mazza A; Armigliato M; Zamboni S; Rempelou P; Rubello D; Pessina AC; Casiglia E
    Minerva Endocrinol; 2008 Dec; 33(4):297-312. PubMed ID: 18923367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapy-resistant hypertension--the endocrinological view].
    Beuschlein F; Reincke M
    MMW Fortschr Med; 2007 Mar; 149(9):29-32. PubMed ID: 17612246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary aldosteronism--careful investigation is essential and rewarding.
    Stowasser M; Gordon RD
    Mol Cell Endocrinol; 2004 Mar; 217(1-2):33-9. PubMed ID: 15134798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case studies in endocrine hypertension.
    Tallis G; Judd S
    Aust Fam Physician; 1996 Mar; 25(3):331-44. PubMed ID: 8867184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.